BridgeMD
Impact of prescribing nonsteroidal anti-inflammatory drugs in pleurodesis surgery after pneumothorax: a prospective randomized controlled double-blind multicenter noninferiority study
EU CTIS ID: 2024-511226-32-00
What this study is testing
show the non-inferiority, in terms of drainage time, of NSAIDs after pleurodesis surgery for the cure of pneumothorax
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Pneumothorax for video-exclusive surgical indication With or without minor lung resection (atypical resection)
- Age > or = 18 years old
- Written or oral informed consent to participate in the study.
- Affiliation to a social security scheme
- Highly effective contraception for women of childbearing age (combined hormonal contraception (estrogen and progesterone) combined with ovulation inhibition (oral, intra-vaginal, transdermal), hormonal contraception (progesterone only) combined with ovulation inhibition (oral, injectable, implantable), intrauterine device, hormone-releasing intrauterine system, bilateral fallopian tube occlusion, vasectomized partner, sexual abstinence, etc.). )
You likely can't join if
- Minor
- Patient under guardianship, curatorship or deprived of liberty
- patient who refuses to participate in the study
- Contraindication to the use of NSAIDs
- Contraindications to the use of TRAMADOL
- Curative anticoagulation
See the full eligibility criteria
- Pneumothorax for video-exclusive surgical indication With or without minor lung resection (atypical resection)
- Age > or = 18 years old
- Written or oral informed consent to participate in the study.
- Affiliation to a social security scheme
- Highly effective contraception for women of childbearing age (combined hormonal contraception (estrogen and progesterone) combined with ovulation inhibition (oral, intra-vaginal, transdermal), hormonal contraception (progesterone only) combined with ovulation inhibition (oral, injectable, implantable), intrauterine device, hormone-releasing intrauterine system, bilateral fallopian tube occlusion, vasectomized partner, sexual abstinence, etc.). )
- Minor
- Patient under guardianship, curatorship or deprived of liberty
- patient who refuses to participate in the study
- Contraindication to the use of NSAIDs
- Contraindications to the use of TRAMADOL
- Curative anticoagulation
- Contraindications to the use of NEFOPAM
- Contraindications to the use of PARACETAMOL
- Contraindications to the use of SODIUM CHLORIDE
- Lactose intolerance
- Hemopneumothorax
- Purulent pleurisy
- Polytraumatized
- Pregnant, parturient or breastfeeding patient
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.